0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Diagnostic Kits of SARS-CoV-2

Diagnostic Kits of SARS-CoV-2

Background
ACRODiagnostics is a new sub-brand of ACROBiosystems, which focuses on providing the R&D, production, and sales of key products and supporting services for the development of biopharmaceuticals, medical diagnostics and will further deepen its strategic layout in the field of precision medicine and companion diagnostics in the future.
Taking big advantage of its group company's accumulation in protein technology and customer relationship, ACRODiagnostics reacts fast to bring its antigen detection kits, neutralizing antibody detection kits and other products to the market when facing the COVID-19 pandemic challenge.
At present, we would like to introduce some diagnostics-related products of SARS-CoV-2 we have successfully developed.
  1. 1. Neutralizing Antibody Detection Kits (ELISA),

  2. 2. Neutralizing Antibody Detection Kits (LFA),

  3. 3. SARS-CoV-2 Antigen Rapid Detection Kit (LFA),

  4. 4. ......

ELISA Kits

Anti-SARS-CoV-2 Neutralizing Antibody Detection Kit (Spike RBD)

Anti-SARS-CoV-2 Neutralizing Antibody Detection Kit (Spike RBD) developed by ACRODagnostics is based on the competitive ELISA method, intended for the detection of SARS-CoV-2 neutralizing antibody that blocks the interaction between the receptor-binding domain of the viral spike glycoprotein (RBD) and the ACE2 cell surface receptor in human serum. SARS-CoV-2 Neutralizing antibody is an important marker for accessing the effectiveness of the novel coronavirus vaccines. The reagent is for neutralizing antibodies detection in samples from individuals after vaccine injection or removed from COVID-19.

High Quality
High sensitivity, specificity and reproducibility
Consistent and reliable performance
Easy to Use
Standardized, color-coded and numbered reagents
Ready-to-use reagents shorten initial prep time
Convenient
All necessary reagents provided
96-microwell plate in re-sealable foil pouch
Shelf life of 12 months

PRODUCT LIST

CategoryCat.No.Product DescriptionsampleRecommended applicationinquiry
SARS-CoV-2
Wild Type
TAS-K022Anti-SARS-CoV-2 Neutralizing Antibody Titer Serologic Assay Kit (CE certified)Human SerumEvaluation of vaccine titer
inquiry
TAS-N035Anti-SARS-CoV-2 Neutralizing Antibody Detection Kit (Spike RBD) (CE certified)Human SerumNeutralizing antibody serological diagnosisinquiry

Principle

The microplate is pre-coated with Human ACE2 Protein. The presence of neutralizing antibodies in samples will compete with ACE2 for HRP- SARS-CoV-2 Spike RBD binding. The intensity of assay signal decrease proportionally to the presence of Anti-SARS-CoV-2 Neutralizing Antibody.

Directions for Use

POCT Products
SARS-CoV-2 Neutralizing Antibody Detection Kit (LFA)
 VLP Platform

The SARS-CoV-2 Neutralizing Antibody Detection Kit can be used for the qualitative detection of SARS-CoV-2 neutralizing antibodies that blocks the interaction between the receptor-binding domain of the viral spike glycoprotein (RBD) and the ACE2 cell surface receptor in human serum, plasma or whole blood. The reagent is for neutralizing antibodies detection in samples from individuals after vaccine injection or removed from COVID-19.

Sensitivity: 97.5 %
Specificity: 98.5 %
Reaction Time: 15min
Sample: serum, plasma, or whole blood
Certification: CE

Directions for Use

> For serum or plasma specimen

Transfer 20μL of serum or plasma vertically into the specimen well (S) of the test strip, then add 100 μL of sample diluent to the specimen well, and timer followed.

> For whole blood specimen

Use blood lancet to prick the fingertip and squeeze the finger to bleed. Use the dropper to take 20μL of fingertip blood (about 1 drop) and add into the specimen well (S) of the test strip. Open the buffer tube by twisting off the top, hold the buffer bottle vertically and 1 cm above the buffer well, add all the sample diluent (Vials with 100 µL) into the specimen well (S) of the test strip.

Nanodisc Platform

Result Interpretation

Nanodisc Platform
SARS-CoV-2 Antigen Rapid Detection Kit (LFA)
Nanodisc Platform

SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold) is a lateral flow immunoassay for the qualitative detection of SARS-COV-2 antigen (nucleocapsid protein) in upper respiratory samples with nasal swabs or saliva during the acute phase of infection. An uncut sheet format is available.

Sensitivity:95%
Specificity:99.56 %
Reaction Time: 15min
Sample: serum, plasma, or whole blood
Certification: CE / Bfarm

Directions for Use

> Nasal Swab Specimen Collection
Nanodisc Platform
> Sample Preparation
Nanodisc Platform

Result Interpretation

Nanodisc Platform

This web search service is supported by Google Inc.

totop